CN102105139B - 制备胃滞留剂型的方法 - Google Patents

制备胃滞留剂型的方法 Download PDF

Info

Publication number
CN102105139B
CN102105139B CN200980128984.9A CN200980128984A CN102105139B CN 102105139 B CN102105139 B CN 102105139B CN 200980128984 A CN200980128984 A CN 200980128984A CN 102105139 B CN102105139 B CN 102105139B
Authority
CN
China
Prior art keywords
agent
dosage form
hydrochloride
adjuvant
dosage forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200980128984.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN102105139A (zh
Inventor
帕斯卡尔·普兰德尔
克里斯托夫·索泽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aix Marseille Universite
Original Assignee
Universite de la Mediterranee Aix Marseille II
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de la Mediterranee Aix Marseille II filed Critical Universite de la Mediterranee Aix Marseille II
Publication of CN102105139A publication Critical patent/CN102105139A/zh
Application granted granted Critical
Publication of CN102105139B publication Critical patent/CN102105139B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN200980128984.9A 2008-06-09 2009-06-08 制备胃滞留剂型的方法 Expired - Fee Related CN102105139B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08290529.0 2008-06-09
EP08290529A EP2133071A1 (en) 2008-06-09 2008-06-09 Process for making gastroretentive dosage forms
PCT/IB2009/005889 WO2009150514A1 (en) 2008-06-09 2009-06-08 Process for making gastroretentive dosage forms

Publications (2)

Publication Number Publication Date
CN102105139A CN102105139A (zh) 2011-06-22
CN102105139B true CN102105139B (zh) 2014-12-31

Family

ID=40219495

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980128984.9A Expired - Fee Related CN102105139B (zh) 2008-06-09 2009-06-08 制备胃滞留剂型的方法

Country Status (7)

Country Link
US (1) US9060930B2 (https=)
EP (2) EP2133071A1 (https=)
JP (2) JP5675598B2 (https=)
CN (1) CN102105139B (https=)
CA (1) CA2727206A1 (https=)
ES (1) ES2561478T3 (https=)
WO (1) WO2009150514A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
EP2444064A1 (en) * 2010-10-22 2012-04-25 Meliatys Process for making multiparticulate gastroretentive dosage forms
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
WO2013114390A1 (en) * 2012-01-02 2013-08-08 Medreich Limited Gastro retentive drug delivery system of calcium supplements
CN113842362A (zh) 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
CN103462926B (zh) * 2013-09-23 2015-09-16 淄博齐鼎立专利信息咨询有限公司 一种泛昔洛韦片剂及其制备方法
WO2015187746A1 (en) 2014-06-02 2015-12-10 Teva Pharmaceutical Industries Ltd. Expandable gastroretentive dosage form
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN110035718B (zh) 2016-12-02 2021-04-06 克雷西奥生物科技有限公司 胃内滞留系统
WO2019111132A1 (en) 2017-12-04 2019-06-13 Clexio Biosciences Ltd. Long acting gastric residence system
AU2018388577B2 (en) * 2017-12-18 2024-06-06 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
CN116459226B (zh) * 2023-04-26 2025-04-18 重庆康刻尔制药股份有限公司 一种铝碳酸镁双层片及其制备方法
CN118526484A (zh) * 2024-07-26 2024-08-23 中国中医科学院中药研究所 青蒿琥酯或双氢青蒿素在制备改善罗格列酮不良反应制剂中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235718A2 (en) * 1986-02-24 1987-09-09 Eisai Co., Ltd. Granule remaining in stomach
US5626876A (en) * 1988-02-05 1997-05-06 Lts Lohmann Therapie-Systeme Gmbh & Co., Kg Floating system for oral therapy
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162986A (da) 1985-04-12 1986-10-13 Forest Laboratories Terapeutisk middel i enhedsdosisform
US4814178A (en) 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
ES2217410T3 (es) * 1996-04-16 2004-11-01 Novartis Consumer Health S.A. Forma de dosificacion oral de rapida desintegracion.
JP2001270827A (ja) * 2000-03-23 2001-10-02 Eisai Co Ltd ベンズイミダゾール系化合物含有錠剤
JP2002154948A (ja) * 2000-11-22 2002-05-28 Eisai Co Ltd 崩壊性に優れた錠剤
US20050202090A1 (en) * 2002-01-03 2005-09-15 Clarke Allan J. Novel pharmaceutical dosage forms and method for producing same
WO2004002445A2 (en) * 2002-06-26 2004-01-08 Cadila Healthcare Limited Novel floating dosage form
US20070269512A1 (en) * 2006-05-22 2007-11-22 Wang Wenhua W Gastroretentive sustained release formulations
US9622966B2 (en) * 2007-07-06 2017-04-18 Basf Corporation Gastroretentive composition on the basis of a water-soluble reaction product from a vinyl group-containing precursor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235718A2 (en) * 1986-02-24 1987-09-09 Eisai Co., Ltd. Granule remaining in stomach
US5626876A (en) * 1988-02-05 1997-05-06 Lts Lohmann Therapie-Systeme Gmbh & Co., Kg Floating system for oral therapy
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition

Also Published As

Publication number Publication date
EP2303241A1 (en) 2011-04-06
US9060930B2 (en) 2015-06-23
EP2133071A1 (en) 2009-12-16
JP2011522873A (ja) 2011-08-04
ES2561478T3 (es) 2016-02-26
JP2015007131A (ja) 2015-01-15
WO2009150514A1 (en) 2009-12-17
JP6054931B2 (ja) 2016-12-27
JP5675598B2 (ja) 2015-02-25
CN102105139A (zh) 2011-06-22
US20120021009A1 (en) 2012-01-26
CA2727206A1 (en) 2009-12-17
EP2303241B1 (en) 2015-11-04

Similar Documents

Publication Publication Date Title
CN102105139B (zh) 制备胃滞留剂型的方法
JP5871939B2 (ja) 多粒子状の胃保持型製剤の製造方法
Badgujar et al. The technologies used for developing orally disintegrating tablets: a review
Garg et al. Progress in controlled gastroretentive delivery systems
Nayak et al. Current developments in orally disintegrating tablet technology
Dobetti Fast-melting tablets: Developments and technologies
ES2347968T3 (es) Preparacion solida que se disgrega rapidamente.
WO2007106960A1 (en) Controlled-release floating dosage forms
EP3398615B1 (en) Mucoadhesive pharmaceutical composition and preparation method therefor
WO2003015745A1 (en) Expandable gastric retention device
JP5513936B2 (ja) 口腔内崩壊製剤
JP2023535829A (ja) コーティングされたａｐｉを含む医薬組成物
WO2012091049A1 (ja) 口腔内崩壊錠剤
BRPI0715756A2 (pt) composiÇço farmacÊutica, uso da mesma e medicamento
JP2010260803A (ja) キサンタンガム被覆水溶性糖類及び圧縮成形製剤
Kumar et al. A review on floating drug delivery systems
HK1189505A (en) Process for making multiparticulate gastroretentive dosage forms
Kanakagiri Sustained Release Floating Matrix Tablets of Ciprofloxacin Using Combination of Different Polymers
EP1891936A1 (de) Gut schluckbare pharmazeutische Zusammensetzung aus einem oder mehreren wirkstoffhaltigen Teilchen ohne unangenehmes Mundgefühl
Kataria et al. FAST DISSOLVING TABLETS: AN OVERVIEW
Gangurde et al. Gastroretentive Dosage Forms: An Overview
BADGUJAR et al. Pregled tehnologija priprave oralno raspadljivih tableta
Patel et al. STUDIES IN DESIGN AND DEVELOPMENT OF STOMACH SPECIFIC DRUG DELIVERY SYSTEM USING VARIOUS APPROACHES
AU2002225872A1 (en) Expandable gastric retention device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141231

Termination date: 20170608